Cian Healthcare Share Price
18.80+0.00 (+0.00%)
+333.18% past 1 Year
Corporate filings & documents
Announcements
As per the Attachment.
2 weeks agoAs per the Attachment.
2 weeks agoAs per the Attachment.
2 weeks agoAs per the Attachment.
2 weeks agoAs per the Attachment.
2 weeks agoAs per the Attachment.
2 weeks agoThe Annual Report for the Financial Year 2025-26 and Notice of the 23rd (Twenty-Third) Annual General Meeting (AGM) of the Company.
2 weeks agoThe Annual Report for the Financial Year 2025-26 and Notice of the 23rd (Twenty-Third) Annual General Meeting (AGM) of the Company.
2 weeks agoAs per the Attachment.
2 weeks agoAs per the Attachment.
2 weeks agoAs per the Attachment
2 weeks agoAs per the Attachment
2 weeks agoAs per the Attachment.
2 weeks agoAs per the Attachment.
2 weeks agoPlease find attached the disclosure under Regulation 30 of the SEBI (LODR) Regulations 2015.
3 weeks agoPlease find attached the disclosure under Regulation 30 of the SEBI (LODR) Regulations 2015.
3 weeks agoAs per the Attachment
4 weeks agoAs per the Attachment
4 weeks agoPlease find attached Scrutinizer Report forming part of Outcome of Postal Ballot.
2 months agoPlease find attached Scrutinizer Report forming part of Outcome of Postal Ballot.
2 months agoPlease find attached Outcome of Postal Ballot.
2 months agoPlease find attached Outcome of Postal Ballot.
2 months agoAs per the attachment.
2 months agoAs per the attachment.
2 months agoAs per the attachment.
2 months agoAs per the attachment.
2 months agoAs per the attachment.
3 months agoAs per the attachment.
3 months agoDisclosure pursuant to Regulation 30 of the SEBI Listing Regulations - Notice of Postal Ballot
3 months agoDisclosure pursuant to Regulation 30 of the SEBI Listing Regulations - Notice of Postal Ballot
3 months agoAs per the Attachment
3 months agoCian Healthcare Limited in its board meeting dated May 30 2026 has approved the audited financial results (Standalone and Consolidated) along with Audit Report and Statement on Impact of Audit Qualification for the half-year and financial year ended March 31 2026
3 months agoCian Healthcare Limited in its board meeting dated May 30 2026 has approved the audited financial results (Standalone and Consolidated) along with Audit Report and Statement on Impact of Audit Qualification for the half-year and financial year ended March 31 2026
3 months agoOutcome of the Board Meeting of Cian Healthcare Limited held on May 30 2026- Audited Financial Results (Standalone and Consolidated) for the half-year and Financial Year ended March 31 2026.
3 months agoNon-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026 as the Company is listed on the SME Platform of BSE Limited.
3 months agoNon-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026 as the Company is listed on the SME Platform of BSE Limited.
3 months agoCian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results (both Standalone and Consolidated) for the half-year and financial year ended on March 31 2026.
3 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Cian Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233PN2003PLC017563</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>13.55</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Rachit Malhotra <br/> Designation: Company Secretary and Cheif Complaince Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Kalyani Vijay Chordia <br/> Designation: Cheif Fianancial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 20/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Cian Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233PN2003PLC017563</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>13.55</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Rachit Malhotra <br/> Designation: Company Secretary and Cheif Complaince Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Kalyani Vijay Chordia <br/> Designation: Cheif Fianancial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 20/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months agoAs per the Disclosure attached.
5 months agoAs per the Disclosure attached.
5 months agoAs per the Disclosure attached.
5 months agoAs per the Disclosure attached.
5 months agoAs per the Intimation attached.
5 months agoAs per the Intimation attached.
5 months agoAs per the attachment.
6 months agoAs per the attachment.
6 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Jain
6 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Jain
6 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ananta Medicare Ltd
6 months agoAnnual reports
Concalls & investor presentations
No presentations found